Abstract
There is a growing demand for replacement alternatives for small-caliber blood vessels, given the significant increase in the prevalence of morbidity and mortality associated with cardiovascular disease observed worldwide. Tissue engineering has emerged as an alternative to traditional autografts and synthetic materials for small vessels and as well as as a promising therapy for coronary …